Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Fixed Capital/Sales

    Back to All Ratios
LASA SUPERGENERICS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

LASA SUPERGENERICS Last 5 Year Fixed Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 2.201.781.681.101.29

What is the latest Fixed Capital/Sales ratio of LASA SUPERGENERICS ?

The latest Fixed Capital/Sales ratio of LASA SUPERGENERICS is 2.20 based on Mar2024 Standalone results.
Year Fixed Capital/Sales
Mar20242.20
Mar20231.78
Mar20221.68
Mar20211.10
Mar20201.29

How is Fixed Capital/Sales of LASA SUPERGENERICS Trending?

Years Fixed Capital/Sales % Change
Mar2024 2.2
23.60
Mar2023 1.78
5.95
Mar2022 1.68
52.73
Mar2021 1.1
-14.73
Mar2020 1.29 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Fixed Capital/Sales ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹45.8 Cr -1.2% -2.4% -62.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,341.0 Cr -1.8% -6.4% -10.7% Stock Analytics
DIVIS LABORATORIES ₹160,401.0 Cr -0.3% -5.5% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,175.0 Cr -0.1% 4% 18.7% Stock Analytics
CIPLA ₹107,100.0 Cr 1% -12.3% -5.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,715.9 Cr -4.6% -7% 1.8% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

-1.2%

-2.4%

-62.5%

SENSEX

-1%

-4.7%

6%


You may also like the below Video Courses